Analysis of the factors that prevent adherence to treatment in patients with diabetes mellitus and the strategies that contribute to the improvement in adherence

This review examined the current problem of low adherence to treatment in patients with chronic diseases, particularly type 2 diabetes mellitus. According to the definition of the World Health Organization, ‘adherence to treatment’ is the degree to which a patient’s behaviour corresponds to the doctor’s recommendations with respect to medications and implementation of dietary advice and/or lifestyle changes. The current medical literature includes a large number of scientific publications devoted to the study of various factors that lead to low adherence to treatment. The term ‘barriers’ is most often used to designate these factors. The first part of this work contains an analysis of the main factors that impede compliance to the doctor’s recommendations, such as socioeconomic and psychological (personal) barriers related to the disease itself, the peculiarities of its treatment and the organisation of medical care (the health care system).

The second part of this review examines the different theoretical models of patient behaviour and strategies that improve adherence to treatment. Most researchers believe that there is an unsatisfactory (low) adherence to treatment and that none of the existing intervention strategies can improve adherence to treatment among all patients. The cornerstone of the entire diabetes management system is the training of patients within the framework of developed structured programmes. Conversely,, success depends on the individual approach, the course of the disease and the mandatory consideration of the individual psychological characteristics of each person. Establishment of a partnership built on trust between a doctor and a patient contributes to greater patient satisfaction with treatment and improved adherence, and this relationship ultimately affects the treatment efficacy and clinical outcomes.

type 2 diabetes mellitus, barriers, patient compliance, theoretical models

1. Старостина Е.Г. Роль комплаентности в ведении больных диабетом // Русский медицинский журнал. – 2015. – Т. 23. – №8. – C. 477-480. [Starostina EG. Rol' komplaentnosti v vedenii bol'nykh diabetom. Russkiy meditsinskiy zhurnal. 2015;23(8):477-480. (In Russ.)]

2. Бергер М., Старостина Е.Г., Йоргенс В., Дедов И.И. Практика инсулинотерапии. – Берлин-Гейдельберг: Springer; 1995. [Berger M, Starostina EG, Jorgens V, Dedov II. Praktika insulinoterapii. Berlin-Heidelberg: Springer; 1995. (In Russ.)]

3. Sabate E.WHO Adherence Meeting Report. Geneva: World Health Organization; 2001.

4. Sabate E, editor. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.

5. Калашникова М.Ф., Бондарева И.Б., Лиходей Н.В. Приверженность лечению при сахарном диабете 2-го типа: определение понятия, современные методы оценки пациентами проводимого лечения // Лечащий врач. – 2015. – №3. – С. 27-33. [Kalashnikova MF, Bondareva IB, Likhodey NV. Commitment to the treatment in 2nd type diabetes mellitus: definition of the notion, modern methods of the treatment assessment by the patients. Practitioner. 2015;(3):27-33. (In Russ.)]

6. American College of Preventive Medicine. Medication education adherence – improving health outcomes. American College of Preventive Medicine; 2011.

7. Hochbaum G, Rosenstock I, Kegels S. Health Belief Model. United States Public Health Service; 1952.

8. Gellad WF, Grenard J, McGlynn EA. A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options. RAND Corporation; 2009.

9. Taha NM, Azeaz MA, Razik BGA. Factors Affecting Compliance of Diabetic Patients toward Therapeutic Management. Med J Cairo Univ. 2011;79(1):211-218.

10. White JR, Jr. Improving Adherence in the Treatment of Type 2 Diabetes. US Pharm. 2010;36(4)(Compliance & Adherence suppl.):11-15.

11. Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag. 2008;4(1):269-286.

12. Delamater AM. Improving Patient Adherence. Clin Diabetes. 2006;24(2):71-77. doi: 10.2337/diaclin.24.2.71

13. Мошняга Е.Н. Особенности течения сахарного диабета при тревожных состояниях: Дис. канд. мед. наук. – М.; 2011. [Moshnyaga EN. Osobennosti techenija sakharnogo diabeta pri trevozhnykh sostojanijakh. [dissertation] Moscow; 2011. (In Russ.)]

14. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs: Prentice-Hall; 1980.

15. Strecher VJ, Champion VL, Rosenstock IM. The health belief model and health behavior. In Gochman DS, editor. Handbook of health behavior research I: Personal and social determinants. New York: Plenum Press; 1997. p. 71-91.

16. Prochaska JO, Redding CA, Evers K. The Transtheoretical Model. In: Glanz KLF, Rimer BK, editors. Health behavior and health education: theory, research, and practice. San Francisco, Jossey-Bass; 1997. p. 99-120.

17. Leventhal H, Leventhal EA, Contrada RJ. Self-regulation, health, and behavior: A perceptual-cognitive approach. Psychol Health. 1998;13(4):717-733. doi: 10.1080/08870449808407425

18. Byrne MK, Deane FP. Treatment adherence. In King R, Lloyd C, Meehan T, et al, editors. Manual of Psychosocial Rehabilitation. Oxford: Wiley-Blackwell; 2012. p. 123-134.

19. Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: making it simple. MedGenMed. 2005;7(1):4.

20. DiMatteo MR, Haskard-Zolnierek KB, Martin LR. Improving patient adherence: a three-factor model to guide practice. Health Psychol Rev. 2012;6(1):74-91. doi: 10.1080/17437199.2010.537592

21. Haug MR, Lavin B. Practitioner or Patient – Who's in Charge? J Health Soc Behav. 1981;22(3):212. doi: 10.2307/2136517

22. Hays RD, DiMatteo MR. A short-form measure of loneliness. J Pers Assess. 1987;51(1):69-81. doi: 10.1207/s15327752jpa5101_6

23. Mishler EG. The Discourse of Medicine: Dialectics of Medical Interviews. Norwood: Ablex Publishing Corporation; 1984.

24. Smith RC. The Patient's Story: Integrating the Patient- and Physician-centered Approaches to Interviewing. Ann Intern Med. 1991;115(6):470. doi: 10.7326/0003-4819-115-6-470

25. Roter DL, Hall JA. Doctors Talking with Patients/patients Talking with Doctors: Improving Communication in Medical Visits. Westport: Auburn House; 1992.

26. Roter D. The enduring and evolving nature of the patient–physician relationship. Patient Educ Couns. 2000;39(1):5-15. doi: 10.1016/s0738-3991(99)00086-5

27. Haidet P, Paterniti DA. "Building" a history rather than "taking" one: a perspective on information sharing during the medical interview. Arch Intern Med. 2003;163(10):1134-1140. doi: 10.1001/archinte.163.10.1134

28. Katz J. Why Doctors Don't Disclose Uncertainty. Hastings Cent Rep. 1984;14(1):35. doi: 10.2307/3560848

29. Wolf SM. Conflict between Doctor and Patient. Law Med Health Care. 2016;16(3-4):197-203. doi: 10.1111/j.1748-720X.1988.tb01946.x

30. Старостина Е.Г., Галстян Г.Р., Дедов И.И. Роль поведения, связанного с диабетом, в эффективности программы лечения и обучения при сахарном диабете I типа // Проблемы эндокринологии. – 1994. – Т. 40. – №5. – C. 39-40. [Starostina EG, Galstjan GR, Dedov II. The role of behavior associated with diabetes in the effectiveness of the program of treatment and education of type 1 diabetes. Problems of endocrinology. 1994;40(5):39-40. (In Russ.)]

31. Antoine SL, Pieper D, Mathes T, Eikermann M. Improving the adherence of type 2 diabetes mellitus patients with pharmacy care: a systematic review of randomized controlled trials. BMC Endocr Disord. 2014;14:53. doi: 10.1186/1472-6823-14-53

32. Raum E, Kramer HU, Ruter G, et al. Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012;97(3):377-384. doi: 10.1016/j.diabres.2012.05.026

33. Rutebemberwa E, Katureebe SK, Gitta SN, et al. Perceptions of diabetes in rural areas of Eastern Uganda. Curationis. 2013;36(1):E1-7. doi: 10.4102/curationis.v36i1.121

34. Abebe SM, Berhane Y, Worku A. Barriers to diabetes medication adherence in North West Ethiopia. Springerplus. 2014;3:195. doi: 10.1186/2193-1801-3-195

35. Vermeire E, Wens J, Van Royen P, et al. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005(2):CD003638. doi: 10.1002/14651858.CD003638.pub2

36. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008(2):CD000011. doi: 10.1002/14651858.CD000011.pub3

37. Старостина Е.Г. Биомедицинские и психосоциальные аспекты сахарного диабета и ожирения: взаимодействие врача и пациента и пути его оптимизации: Дис. д-ра мед. наук. – М.; 2003. [Starostina EG. Biomeditsinskiye i psikhosotsial’nyye aspekty sakharnogo diabeta i ozhireniya: vzaimodeystviye vracha i patsiyenta i puti jego optimizatsii. [dissertation] Moscow; 2003. (In Russ.)]

38. Приказ Министерства здравоохранения Российской Федерации № 973н от 19 декабря 2016 г. «Об утверждении типовых отраслевых норм времени на выполнение работ, связанных с посещением одним пациентом врача-кардиолога, врача-эндокринолога, врача-стоматолога-терапевта». [Decree of the Ministry of healthcare of the Russian Federation № 973n of 19 December 2016. «Ob utverzhdenii tipovykh otraslevykh norm vremeni na vypolnenie rabot, svyazannykh s poseshcheniem odnim patsientom vracha-kardiologa, vracha-endokrinologa, vracha-stomatologa-terapevta». (In Russ.)]

39. Дедов И.И., Калашникова М.Ф., Белоусов Д.Ю., и др. Фармакоэпидемиологические аспекты мониторинга здоровья пациентов с сахарным диабетом 2 типа: результаты Российского наблюдательного многоцентрового эпидемиологического исследования ФОРСАЙТ-СД 2 // Сахарный диабет. – 2016. – Т. 19. – №6. – С. 443-456. [Dedov II, Kalashnikova MF, Belousov DY, et al. Assessing routine healthcare pattern for type 2 diabetes mellitus In Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2). Diabetes mellitus. 2016;19(6):443-456. (In Russ.)] doi: 10.14341/DM8146

40. Hamilton GA, Toberts SJ, Johnson JM, et al. Increasing adherence in patients with primary hypertension: an intervention. Am J Health Behav. 1993;17(1):3-11.

41. Cheng TL, Ottolini MC, Baumhaft K, et al. Strategies to Increase Adherence With Tuberculosis Test Reading in a High-risk Population. Pediatrics. 1997;100(2):210-213. doi: 10.1542/peds.100.2.210

42. Roter DL, Hall JA, Merisca R, et al. Effectiveness of Interventions to Improve Patient Compliance. Med Care. 1998;36(8):1138-1161. doi: 10.1097/00005650-199808000-00004

43. MacDonald PE, Sewing S, Wang J, et al. Inhibition of Kv2.1 voltage-dependent K+ channels in pancreatic beta-cells enhances glucose-dependent insulin secretion. J Biol Chem. 2002;277(47):44938-44945. doi: 10.1074/jbc.M205532200 l

44. Martin LR, Williams SL, Haskard KB, DiMatteo RM. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189–199.